SEK 3.06
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -8.26 Million SEK | 33.9% |
2022 | -12.5 Million SEK | 62.02% |
2021 | -32.92 Million SEK | -940.97% |
2020 | 3.91 Million SEK | 6.13% |
2019 | 3.68 Million SEK | -5.31% |
2018 | 3.89 Million SEK | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -4.83 Million SEK | 12.94% |
2024 Q1 | -5.55 Million SEK | 32.75% |
2024 Q3 | -5.34 Million SEK | -10.46% |
2023 Q3 | -9.55 Million SEK | 17.56% |
2023 FY | -8.26 Million SEK | 33.9% |
2023 Q1 | -12.89 Million SEK | -3.13% |
2023 Q4 | -8.26 Million SEK | 13.48% |
2023 Q2 | -11.58 Million SEK | 10.14% |
2022 Q3 | -16.08 Million SEK | 14.08% |
2022 FY | -12.5 Million SEK | 62.02% |
2022 Q2 | -18.71 Million SEK | 33.06% |
2022 Q1 | -27.96 Million SEK | 15.07% |
2022 Q4 | -12.5 Million SEK | 22.25% |
2021 Q1 | 29 Thousand SEK | -99.26% |
2021 FY | -32.92 Million SEK | -940.97% |
2021 Q4 | -32.92 Million SEK | -920.64% |
2021 Q3 | 4.01 Million SEK | 8.08% |
2021 Q2 | 3.71 Million SEK | 12700.0% |
2020 FY | 3.91 Million SEK | 6.13% |
2020 Q4 | 3.91 Million SEK | -24.93% |
2020 Q3 | 5.21 Million SEK | 0.0% |
2020 Q1 | - SEK | 0.0% |
2019 FY | 3.68 Million SEK | -5.31% |
2018 FY | 3.89 Million SEK | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Aino Health AB (publ) | -1.27 Million SEK | -550.275% |
Bonzun AB (publ) | 351 Thousand SEK | 2454.701% |
Kontigo Care AB (publ) | -3.9 Million SEK | -111.814% |
RaySearch Laboratories AB (publ) | 185.67 Million SEK | 104.451% |
Surgical Science Sweden AB (publ) | -581.1 Million SEK | 98.578% |